Clinical Care Options Prostate Cancer This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Use of Ipilimumab in Metastatic CRPC That Progressed After Docetaxel
Slideset - Ipilimumab after docetaxel failed to significantly prolong overall survival compared with placebo in the intent-to-treat analysis but showed evidence of antitumor activity and stronger benefit in patients with favorable prognostic factors. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - October 30, 2014 Category: Cancer & Oncology Source Type: research

Use of Ipilimumab in Metastatic Castration-Resistant Prostate Cancer That Progressed After Docetaxel
JO Capsule - Ipilimumab after bone-directed radiotherapy failed to significantly prolong overall survival compared with placebo in the intent-to-treat analysis but showed evidence of antitumor activity and stronger benefit in patients with favorable prognostic factors. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - October 9, 2014 Category: Cancer & Oncology Source Type: research

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Journal Article - (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - October 9, 2014 Category: Cancer & Oncology Source Type: research

CCO Independent Conference Coverage of the 2014 Genitourinary Cancers Symposium
Slideset - Brian Rini, MD, FACP, and Nicholas J. Vogelzang, MD, provide expert perspective on the clinical applicability of key study findings in prostate cancer, renal cell carcinoma, bladder cancer, and germ cell tumors. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - April 8, 2014 Category: Cancer & Oncology Source Type: research

CCO Independent Conference Coverage of the 2014 Genitourinary Cancers Symposium
Slideset Module - Brian Rini, MD, FACP, and Nicholas J. Vogelzang, MD, provide expert perspective on the clinical applicability of key study findings in prostate cancer, renal cell carcinoma, bladder cancer, and germ cell tumors. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - April 8, 2014 Category: Cancer & Oncology Source Type: research

Radionuclide-Based Therapy for Metastatic CRPC: Multidisciplinary Considerations
Slideset - In this downloadable slideset, Daniel P. Petrylak, MD, and Chaitanya R. Divgi, MD, MBBS, examine best practices and the supporting evidence for the clinical use of the new radionuclide therapy for patients with metastatic castration-resistant prostate cancer. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - February 7, 2014 Category: Cancer & Oncology Source Type: research

Radionuclide-Based Therapy for Metastatic Castration-Resistant Prostate Cancer: Multidisciplinary Considerations
Interactive Virtual Presentation - In this interactive virtual presentation, Daniel P. Petrylak, MD and Chaitanya R. Divgi, MD, MBBS, discuss recent developments in the management of castration-resistant prostate cancer using radionuclide therapy including the underlying rationale, patient selection, administration and handling issues, and integration into the rapidly evolving treatment paradigm for this malignancy. (Source: Clinical Care Options Prostate Cancer)
Source: Clinical Care Options Prostate Cancer - February 7, 2014 Category: Cancer & Oncology Source Type: research

CCO Independent Conference Coverage of the 2011 ASCO Genitourinary Cancers Symposium
CCO Slideset - Download slides on recent data in prostate, renal, and bladder cancer from the 2011 Genitourinary Cancers Symposium. (Source: Clinical Care Options Oncology - Prostate Cancer)
Source: Clinical Care Options Oncology - Prostate Cancer - May 26, 2011 Category: Cancer & Oncology Source Type: research

CCO Independent 2010 Conference Coverage of the 35th Congress of the European Society of Medical Oncology
Learning Module - David J. Kerr, CBE, MA, MD, DSc, FRCP, FRCGP, and Nicholas J. Vogelzang, MD, discuss the most clinically relevant new data reported at the 35th European Society for Medical Oncology Congress. (Source: Clinical Care Options Oncology - Prostate Cancer)
Source: Clinical Care Options Oncology - Prostate Cancer - December 27, 2010 Category: Cancer & Oncology Source Type: research

Adjuvant Paclitaxel/Gemcitabine/Cisplatin Improves Survival in Patients With Resected Locally Invasive Bladder Cancer
Capsule Summary - Compared with observation, adjuvant PGC significantly improved all efficacy outcomes, including OS, in patients with resected invasive transitional cell carcinoma of the bladder. (Source: Clinical Care Options Oncology - Prostate Cancer)
Source: Clinical Care Options Oncology - Prostate Cancer - June 11, 2010 Category: Cancer & Oncology Source Type: research